Kiniksa Pharmaceuticals International, plc (KNSA) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $77.67M | +27.5% |
| 2024 | $60.91M | +82.3% |
| 2023 | $33.41M | +45.9% |
| 2022 | $22.89M | +151.6% |
| 2021 | $9.10M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $77.67M | +27.5% |
| 2024 | $60.91M | +82.3% |
| 2023 | $33.41M | +45.9% |
| 2022 | $22.89M | +151.6% |
| 2021 | $9.10M | — |